Beam Therapeutics Inc. P/FCF ratio

P/FCF ratio of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/FCF ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its free cash flow per share. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low P/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current P/FCF ratio of Beam Therapeutics Inc. is 0.0 (as of December 31, 2021)
  • P/FCF ratio for the quarter ending September 30, 2022 was 84.86 (a 284.06% increase compared to previous quarter)
  • Year-over-year quarterly P/FCF ratio increased by Infinity%
  • Annual P/FCF ratio for 2021 was 0.0 (a NaN% decrease from previous year)
  • Annual P/FCF ratio for 2020 was 0.0 (a NaN% decrease from previous year)
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/FCF ratio of Beam Therapeutics Inc.

Most recent P/FCF ratioof BEAM including historical data for past 10 years.

Interactive Chart of P/FCF ratio of Beam Therapeutics Inc.

Beam Therapeutics Inc. P/FCF ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 84.86 22.1 26.56 –
2021 0.0 0.0 0.0 0.0 0.0
2020 0.0 0.0 0.0 0.0 0.0
2019 0.0 0.0 0.0 – 0.0

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com